Wow - quite an amazing benefit conferred with this new shortened timeframe.
I wonder if that changes things for us? I know that JP has talked in investment seminars and webinars after company announcements about the option to progress to a pharma that sells, but he has always seemed quite dismissive. He has said if shareholders wanted it, they company would consider it but it did not seem genuine.
I could be totally wrong but I sensed a slightly different appetite in his interview with Alan Kohler recently and this news might further change the mind or at least provide pause for thought.
Wow - quite an amazing benefit conferred with this new shortened...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.91 |
Change
1.370(10.9%) |
Mkt cap ! $1.729B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $12.06M | 879.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 256 | $13.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.91 | 1310 | 6 |
View Market Depth
| Last trade - 13.47pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |